丽 珠B:第三季度报告全文(英文版) .ppt
《丽 珠B:第三季度报告全文(英文版) .ppt》由会员分享,可在线阅读,更多相关《丽 珠B:第三季度报告全文(英文版) .ppt(19页珍藏版)》请在三一办公上搜索。
1、I.,0%,-,-,The 2012 Third Quarterly Report of Livzon Pharmaceutical Group Inc.The 2012 Third Quarterly Report of Livzon Pharmaceutical Group Inc.Important noticeThe Board of Directors(BOD),Board of Supervisors(BOS),directors,supervisors,and senior executives herebyguarantee that the data in the prese
2、nt report contain no false representation,misleading statements and seriousomissions,and shall be severally and jointly liable for the authenticity,accuracy and completeness of the content.All directors attended the shareholders meeting that examined this report.Mr.Zhu Baoguo,principal of the Compan
3、y,Mr.An Ning,the principal in charge of accounting,and Ms.Si Yanxia,theprincipal of the Accounting Department hereby declare:We guarantee the authenticity and completeness of the FinancialReport in this quarterly report.II.Brief introduction of the Company(II)Financial highlights,2012.9.30,2011.12.3
4、1,Increase or decrease(%),Total assets(RMB Yuan),5,463,602,547.19,4,602,908,981.74,18.70%,Owners equity attributable,to the shareholders of listed,2,917,553,597.53,2,843,169,706.20,2.62%,company(RMB Yuan),Share capital(Share)Net asset per share,295,721,852.00,295,721,852.00,attributable to theshareh
5、olders of listed,9.87,9.61,2.71%,company(RMB Yuan/share),Increase or decrease,Increase or decrease,July to September2012,compared with thesame period ofprevious year(%),January toSeptember 2012,compared with thesame period ofprevious year(%),Total operatingincome(RMB Yuan),1,024,017,114.12,29.23%,2,
6、909,014,289.56,28.50%,Net profit attributable to,shareholders of listed,114,925,845.48,91.57%,343,630,861.87,22.35%,company(RMB Yuan)Net cash flows from,operating activities(RMBYuan)Net cash flows per share,529,219,276.51,29.70%,from operating activities,-,-,1.79,29.71%,(RMB Yuan/share),Basic profit
7、 per share(RMBYuan/share)Diluted profit per share(RMB Yuan/share)Weighed yield rate of netasset(%),0.390.393.93%,95%95%Up 1.66 percentage points,1.161.1611.93%,22.11%22.11%Up 1.29 percentage points,Weighed yield rate of net,assets after deduction ofnon-recurring profit and loss,3.80%,Up 1.05 percent
8、age points,11.41%,Up 1.01 percentagepoints,(%)1,0.,The 2012 Third Quarterly Report of Livzon Pharmaceutical Group Inc.The items of non-recurring profit and loss(January to September 2012)Amount from the,Items of non-recurring profit and lossProfit and loss in disposal of non-circulation assetsGovern
9、mental allowance accrued to the current profitand loss(except those that are closely related to thenormal operation businesses of company,complywith the national policies,and are continuouslygranted based on the certain standard quota orcertain quantity)Except the effective hedge business related to
10、 thenormal operation business of the company,the profitand loss in the changes of fair values caused by theholding of tradable financial assets and tradablefinancial liabilities as well as the investment returns indisposal of tradable financial assets,tradablefinancial liabilities and saleable finan
11、cial assetsOther net non-operating income and payment exceptthe above itemsOther profit and loss items that comply with the non-recurring profit and loss definitionSubtotalMinus:effect of equities attributable to the minority ofshareholdersMinus:effect of income taxTotal,year beginning toend of repo
12、rt period-2,619,231.6415,039,354.116,392,098.36529,231.2019,341,452.033,554,087.31761125.2615,026,239.46,Note-,(II)Table about total quantity of all shareholders and shareholding particulars of top tenshareholders at the end of report periodTotal quantity of,shareholders at the end of,The shareholde
13、r quantity amounted to 23,004(including 8,296 B-share holders),report periodShares held by top ten shareholders without trading restriction,Quantity of shareswithout trading,Share type and quantity,Shareholder name,restriction at theend of report,Type,Quantity,period,Joincare PharmaceuticalIndustry
14、Co.,Ltd,Group,77,510,167,RMB Common share,77,510,167,Tiancheng Industry Co.,LtdGAOLING FUND,L.P.First Shanghai Securities Co.,LtdAgricultural Bank of China LOFShenzhen Haibin Pharmaceutical Co.,Ltd,50,660,05210,258,11210,219,7706,968,8035,892,943,Domestically-listed sharesfor overseas investorsDomes
15、tically-listed sharesfor overseas investorsDomestically-listed sharesfor overseas investorsRMB Common shareRMB Common share,50,660,05210,258,11210,219,7706,968,8035,892,943,Agricultural Bank of China Greatwall,Anxin,Huibao,Mixed,Securities,5,700,000,RMB Common share,5,700,000,Investment Fund,Industr
16、ial and Commercial Bank ofChina Jiashi Strategic Growth Mixed-t,4,783,021,RMB Common share,4,783,021,2,2.,-,8,The 2012 Third Quarterly Report of Livzon Pharmaceutical Group Inc.ype Securities Investment FundBank of Communications Greatwall,Jiufu,Core,Growth,Stock-type,4,725,389,RMB Common share,4,72
17、5,389,Securities Investment Fund(LOF)Agricultural Bank of China-Invesco,Great Wall Internal Demand Growth II,4,422,792,RMB Common share,4,422,792,Stock-type Securities Investment FundIII.Major events(I)Great changes and reasons of main financial statement items and financial indexes of theCompany Ap
18、plicable Inapplicable1.Items in the Balance Sheet,Items in theBalanceSheetAccountsreceivableOtheraccountsreceivable,2012.9.30742,315,684.7959,213,582.77,2011.12.31562,146,013.1844,488,052.86,Changerate32.05%33.10%,ReasonThe main reason is the increase of salesincomes.The main reason is the increase
19、of advancemoney in the sales business.,Engineering,The main reason is the increase of expenses in,under,841,353,722.78,148,841,628.16,465.27%,the new factory construction and technical,construction,improvement.The main reason is that the technical,Engineeringgoods,3,543,796.60,2,536,926.00,39.69%,im
20、provement equipment purchased by LiminPharmaceutical Factory has not been installed,for the time being.The main reasons include:1)the increase of raw,Accountspayable,310,282,503.70,207,941,294.31,49.22%,materials purchased by all productionenterprises;2)the increase of unsettled,engineering projects
21、 in the headquarters.The main reason is that the difference between,Capitalreserve,227,795,132.23,348,093,136.41,-34.56%,the equities of the minority of shareholders inLimin Pharmaceutical Factory and net asset,shares offset the capital reserve.,Interestspayable,5,538,181.90,16,841,492.68,-67.12%,Th
22、e main reason is the interests of short-termfinancing bonds of RMB 400 million Yuan thathas been due.,The items in the Profit Statement from the year beginning to the end of report period,Items in the ProfitStatementOperating tax andsurtaxSales expenseAsset depreciationlossProfits fromthe,January to
23、September201240,442,078.861,062,612,062.7218,031,136.93,January toSeptember201128,300,021.22658,489,170.6310,790,557.01,Changerate42.90%61.37%67.10%,ReasonThe main reason is the increase of city constructiontax and education surtax that are withdrawn due tothe increase of sales incomes.The main reas
24、on is the increase of relevant businessinvestments due to the increase of sales incomes.The main reason is the increase of bad debt lossand depreciation loss of inventory.The main reason is the increase of changes of fair,changes of,fair,4,800,246.93,15,329,948.1,131.31%,values of tradable financial
25、 assets held by the,values,company.,Investment returns,1,668,506.76,1,142,974.78,45.98%,The main reason is the increase of investmentreturns from associated enterprises.,3,3.,-,The 2012 Third Quarterly Report of Livzon Pharmaceutical Group Inc.,Non-operatingincomes,15,945,423.03,27,503,971.07,-42.03
- 配套讲稿:
如PPT文件的首页显示word图标,表示该PPT已包含配套word讲稿。双击word图标可打开word文档。
- 特殊限制:
部分文档作品中含有的国旗、国徽等图片,仅作为作品整体效果示例展示,禁止商用。设计者仅对作品中独创性部分享有著作权。
- 关 键 词:
- 珠:第三季度报告全文英文版 第三 季度 报告 全文 英文
链接地址:https://www.31ppt.com/p-2936537.html